Skip to main content
NCBI home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 1997 Sep;77(2):F147–F150. doi: 10.1136/fn.77.2.f147

Effects of antenatal and postnatal corticosteroids on the preterm lung

J Vyas, S Kotecha
PMCID: PMC1720703  PMID: 9377142

Full Text

The Full Text of this article is available as a PDF (82.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamson I. Y., King G. M. Postnatal development of rat lung following retarded fetal lung growth. Pediatr Pulmonol. 1988;4(4):230–236. doi: 10.1002/ppul.1950040408. [DOI] [PubMed] [Google Scholar]
  2. Arnon S., Grigg J., Silverman M. Pulmonary inflammatory cells in ventilated preterm infants: effect of surfactant treatment. Arch Dis Child. 1993 Jul;69(1 Spec No):44–48. doi: 10.1136/adc.69.1_spec_no.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Asayama K., Hayashibe H., Dobashi K., Uchida N., Kato K. Effect of dexamethasone on antioxidant enzymes in fetal rat lungs and kidneys. Biol Neonate. 1992;62(2-3):136–144. doi: 10.1159/000243866. [DOI] [PubMed] [Google Scholar]
  4. Ashton M. R., Postle A. D., Smith D. E., Hall M. A. Surfactant phosphatidylcholine composition during dexamethasone treatment in chronic lung disease. Arch Dis Child. 1994 Sep;71(2):F114–F117. doi: 10.1136/fn.71.2.f114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Avery G. B., Fletcher A. B., Kaplan M., Brudno D. S. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics. 1985 Jan;75(1):106–111. [PubMed] [Google Scholar]
  6. Bagchi A., Viscardi R. M., Taciak V., Ensor J. E., McCrea K. A., Hasday J. D. Increased activity of interleukin-6 but not tumor necrosis factor-alpha in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia. Pediatr Res. 1994 Aug;36(2):244–252. doi: 10.1203/00006450-199408000-00017. [DOI] [PubMed] [Google Scholar]
  7. Beck J. C., Mitzner W., Johnson J. W., Hutchins G. M., Foidart J. M., London W. T., Palmer A. E., Scott R. Betamethasone and the rhesus fetus: effect on lung morphometry and connective tissue. Pediatr Res. 1981 Mar;15(3):235–240. doi: 10.1203/00006450-198103000-00007. [DOI] [PubMed] [Google Scholar]
  8. Bunton T. E., Plopper C. G. Triamcinolone-induced structural alterations in the development of the lung of the fetal rhesus macaque. Am J Obstet Gynecol. 1984 Jan 15;148(2):203–215. doi: 10.1016/s0002-9378(84)80177-5. [DOI] [PubMed] [Google Scholar]
  9. Crowley P. A. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol. 1995 Jul;173(1):322–335. doi: 10.1016/0002-9378(95)90222-8. [DOI] [PubMed] [Google Scholar]
  10. Cummings J. J., D'Eugenio D. B., Gross S. J. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med. 1989 Jun 8;320(23):1505–1510. doi: 10.1056/NEJM198906083202301. [DOI] [PubMed] [Google Scholar]
  11. Fardy C. H., Silverman M. Antioxidants in neonatal lung disease. Arch Dis Child Fetal Neonatal Ed. 1995 Sep;73(2):F112–F117. doi: 10.1136/fn.73.2.f112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Frank L., Lewis P. L., Sosenko I. R. Dexamethasone stimulation of fetal rat lung antioxidant enzyme activity in parallel with surfactant stimulation. Pediatrics. 1985 Mar;75(3):569–574. [PubMed] [Google Scholar]
  13. Frank L. Prenatal dexamethasone treatment improves survival of newborn rats during prolonged high O2 exposure. Pediatr Res. 1992 Aug;32(2):215–221. doi: 10.1203/00006450-199208000-00018. [DOI] [PubMed] [Google Scholar]
  14. Frank L., Sosenko I. R. Prenatal development of lung antioxidant enzymes in four species. J Pediatr. 1987 Jan;110(1):106–110. doi: 10.1016/s0022-3476(87)80300-1. [DOI] [PubMed] [Google Scholar]
  15. Greenspan J. S., Abbasi S., Bhutani V. K. Sequential changes in pulmonary mechanics in the very low birth weight (less than or equal to 1000 grams) infant. J Pediatr. 1988 Oct;113(4):732–737. doi: 10.1016/s0022-3476(88)80391-3. [DOI] [PubMed] [Google Scholar]
  16. Groneck P., Reuss D., Götze-Speer B., Speer C. P. Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease. J Pediatr. 1993 Jun;122(6):938–944. doi: 10.1016/s0022-3476(09)90024-5. [DOI] [PubMed] [Google Scholar]
  17. Groneck P., Speer C. P. Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed. 1995 Jul;73(1):F1–F3. doi: 10.1136/fn.73.1.f1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Harkavy K. L., Scanlon J. W., Chowdhry P. K., Grylack L. J. Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: a controlled trial. J Pediatr. 1989 Dec;115(6):979–983. doi: 10.1016/s0022-3476(89)80754-1. [DOI] [PubMed] [Google Scholar]
  19. Hislop A. A., Wigglesworth J. S., Desai R., Aber V. The effects of preterm delivery and mechanical ventilation on human lung growth. Early Hum Dev. 1987 May;15(3):147–164. doi: 10.1016/0378-3782(87)90003-x. [DOI] [PubMed] [Google Scholar]
  20. Kazzi N. J., Brans Y. W., Poland R. L. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Pediatrics. 1990 Nov;86(5):722–727. [PubMed] [Google Scholar]
  21. Keeney S. E., Mathews M. J., Rassin D. K. Antioxidant enzyme responses to hyperoxia in preterm and term rats after prenatal dexamethasone administration. Pediatr Res. 1993 Feb;33(2):177–180. doi: 10.1203/00006450-199302000-00017. [DOI] [PubMed] [Google Scholar]
  22. Kojima T., Sasai M., Kobayashi Y. Increased soluble ICAM-1 in tracheal aspirates of infants with bronchopulmonary dysplasia. Lancet. 1993 Oct 23;342(8878):1023–1024. doi: 10.1016/0140-6736(93)92880-3. [DOI] [PubMed] [Google Scholar]
  23. Kotecha S., Chan B., Azam N., Silverman M., Shaw R. J. Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child Fetal Neonatal Ed. 1995 Mar;72(2):F90–F96. doi: 10.1136/fn.72.2.f90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kotecha S. Cytokines in chronic lung disease of prematurity. Eur J Pediatr. 1996 Aug;155 (Suppl 2):S14–S17. doi: 10.1007/BF01958074. [DOI] [PubMed] [Google Scholar]
  25. Kotecha S., Wangoo A., Silverman M., Shaw R. J. Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. J Pediatr. 1996 Apr;128(4):464–469. doi: 10.1016/s0022-3476(96)70355-4. [DOI] [PubMed] [Google Scholar]
  26. Kotecha S., Wilson L., Wangoo A., Silverman M., Shaw R. J. Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res. 1996 Aug;40(2):250–256. doi: 10.1203/00006450-199608000-00010. [DOI] [PubMed] [Google Scholar]
  27. Liggins G. C., Howie R. N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972 Oct;50(4):515–525. [PubMed] [Google Scholar]
  28. Liley H. G., White R. T., Warr R. G., Benson B. J., Hawgood S., Ballard P. L. Regulation of messenger RNAs for the hydrophobic surfactant proteins in human lung. J Clin Invest. 1989 Apr;83(4):1191–1197. doi: 10.1172/JCI114000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Little S., Dean T., Bevin S., Hall M., Ashton M., Church M., Warner J., Shute J. Role of elevated plasma soluble ICAM-1 and bronchial lavage fluid IL-8 levels as markers of chronic lung disease in premature infants. Thorax. 1995 Oct;50(10):1073–1079. doi: 10.1136/thx.50.10.1073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. MacArthur B. A., Howie R. N., Dezoete J. A., Elkins J. School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics. 1982 Jul;70(1):99–105. [PubMed] [Google Scholar]
  31. Mammel M. C., Green T. P., Johnson D. E., Thompson T. R. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet. 1983 Jun 18;1(8338):1356–1358. doi: 10.1016/s0140-6736(83)92139-6. [DOI] [PubMed] [Google Scholar]
  32. Margraf L. R., Tomashefski J. F., Jr, Bruce M. C., Dahms B. B. Morphometric analysis of the lung in bronchopulmonary dysplasia. Am Rev Respir Dis. 1991 Feb;143(2):391–400. doi: 10.1164/ajrccm/143.2.391. [DOI] [PubMed] [Google Scholar]
  33. Massaro D., Teich N., Maxwell S., Massaro G. D., Whitney P. Postnatal development of alveoli. Regulation and evidence for a critical period in rats. J Clin Invest. 1985 Oct;76(4):1297–1305. doi: 10.1172/JCI112103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Murch S. H., MacDonald T. T., Wood C. B., Costeloe K. L. Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment. Thorax. 1992 Jan;47(1):44–47. doi: 10.1136/thx.47.1.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Noble-Jamieson C. M., Regev R., Silverman M. Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications. Eur J Pediatr. 1989 Jan;148(4):365–367. doi: 10.1007/BF00444135. [DOI] [PubMed] [Google Scholar]
  36. Ogden B. E., Murphy S. A., Saunders G. C., Pathak D., Johnson J. D. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis. 1984 Nov;130(5):817–821. doi: 10.1164/arrd.1984.130.5.817. [DOI] [PubMed] [Google Scholar]
  37. Ohlsson A., Calvert S. A., Hosking M., Shennan A. T. Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilator-dependent chronic lung disease. Acta Paediatr. 1992 Oct;81(10):751–756. doi: 10.1111/j.1651-2227.1992.tb12096.x. [DOI] [PubMed] [Google Scholar]
  38. Rastogi A., Akintorin S. M., Bez M. L., Morales P., Pildes R. S. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Pediatrics. 1996 Aug;98(2 Pt 1):204–210. [PubMed] [Google Scholar]
  39. Sanders R. J., Cox C., Phelps D. L., Sinkin R. A. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr Res. 1994 Jul;36(1 Pt 1):122–128. doi: 10.1203/00006450-199407001-00022. [DOI] [PubMed] [Google Scholar]
  40. Schellhase D. E., Shannon J. M. Effects of maternal dexamethasone on expression of SP-A, SP-B, and SP-C in the fetal rat lung. Am J Respir Cell Mol Biol. 1991 Apr;4(4):304–312. doi: 10.1165/ajrcmb/4.4.304. [DOI] [PubMed] [Google Scholar]
  41. Shinwell E. S., Karplus M., Zmora E., Reich D., Rothschild A., Blazer S., Bader D., Yurman S., Dolfin T., Kuint J. Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed. 1996 Jan;74(1):F33–F37. doi: 10.1136/fn.74.1.f33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Tschanz S. A., Damke B. M., Burri P. H. Influence of postnatally administered glucocorticoids on rat lung growth. Biol Neonate. 1995;68(4):229–245. doi: 10.1159/000244241. [DOI] [PubMed] [Google Scholar]
  43. Wang J. Y., Yeh T. F., Lin Y. C., Miyamura K., Holmskov U., Reid K. B. Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome. Thorax. 1996 Sep;51(9):907–913. doi: 10.1136/thx.51.9.907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Weaver T. E., Whitsett J. A. Function and regulation of expression of pulmonary surfactant-associated proteins. Biochem J. 1991 Jan 15;273(Pt 2):249–264. doi: 10.1042/bj2730249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Wiebicke W., Poynter A., Chernick V. Normal lung growth following antenatal dexamethasone treatment for respiratory distress syndrome. Pediatr Pulmonol. 1988;5(1):27–30. doi: 10.1002/ppul.1950050107. [DOI] [PubMed] [Google Scholar]
  46. Yeh T. F., Torre J. A., Rastogi A., Anyebuno M. A., Pildes R. S. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J Pediatr. 1990 Aug;117(2 Pt 1):273–282. doi: 10.1016/s0022-3476(05)80547-5. [DOI] [PubMed] [Google Scholar]
  47. Yoder M. C., Jr, Chua R., Tepper R. Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia. Am Rev Respir Dis. 1991 May;143(5 Pt 1):1044–1048. doi: 10.1164/ajrccm/143.5_Pt_1.1044. [DOI] [PubMed] [Google Scholar]
  48. Yoder M. C., Jr, Chua R., Tepper R. Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia. Am Rev Respir Dis. 1991 May;143(5 Pt 1):1044–1048. doi: 10.1164/ajrccm/143.5_Pt_1.1044. [DOI] [PubMed] [Google Scholar]
  49. Zimmerman J. J. Bronchoalveolar inflammatory pathophysiology of bronchopulmonary dysplasia. Clin Perinatol. 1995 Jun;22(2):429–456. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES